ARDIS · Autoimmunity and rheumatic disease research groups
FP6 — Marie Curie Actions (Human Resources and Mobility)
- Duration
- 2005-07-01 → 2009-06-30
- EU contribution
- €1,714,390
- Participants
- 6
- Scheme
- EST
Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.
Results in brief
Final Activity Report Summary - ARDIS (Autoimmunity and rheumatic disease research groups)
Research groups in autoimmunity at the Universities of Bergen, Lund / Karolinska Institute, Erlangen / Frankfurt and Oxford have provided early stage training for nine PhD students in immunology, genetics and molecular medicine of Rheumatoid arthritis (RA), Sjögren's syndrome (SS) and Multiple sclerosis (MS). This training was based on a broad integrated approach with the aim of initiating a better understanding of the immunopathogenesis and genetic background of autoimmune diseases in general. The long-term objectives was to reach a more fundamental basis for better diagnosis and treatment in these chronic, disabling and enigmatic diseases affecting a large part of the European population. The area of research training was autoimmune reactions, disease mechanisms and genetics with basis in both human and murine model systems. The exploration of genetic markers of these autoimmune diseases was seen as an integral part of making progress in understanding; it provided vital clues to focus immunological studies in the future leading to intervention in RA, SS and MS and pointing the way forward for other similar diseases. In short, the PhD trainees were confronted with the following aspects during training: -characterisation of the target structures of autoimmune responses for an improvement of diagnostic tools and eventually the development of antigen-specific immunomodulatory strategies; - positional cloning of genes responsible for animal model diseases corresponding to human RA, MS and SS; - in depth studies on the pathogenic pathways leading to RA, MS and SS, primarily using congenic and specifically mutated strains; - establishment and studies of humanised mice. These mice are humanized with the human homologous genes identified in the animal models like MHC class II and type II collagen; - establishment of a higher plateau in the knowledge base and enhanced treatment strategies that can be applied, in whole or in part, to other autoimmune diseases.
Data: CORDIS, © European Union
Project objective
AUTOIMMUNITY research groups at the Universities of Bergen, Lund, Erlangen and Oxford will offer earlystage training in immunology, genetics and molecular medicine of rheumatoid arthritis (RA), Sjogren'ssyndrome (SS) and multiple sclerosis (MS). This train ing is based on a broad integrated disciplinary approachwith the aim of initiating a better understanding of the common features of the immunopathogenesis andcommon genetic background of autoimmune diseases in general. The long-term objectives are to reach a morefundamental basis for better diagnosis and treatment in these chronic, disabling and enigmatic diseases affectinga large part (5-6 mill.) of the European population. The area of research training is autoimmune reactions,disease mechanisms and geneti cs with basis in both human and murine model systems. By using severalcomplementary strategies this European training intends to reveal a picture of molecular, genetic and clinicalmarkers for the diagnosis and progression of RA, SS and MS. It will do so by analysing the complexmechanisms by which organ-specific inflammation of RA, SS and MS develops and persists. The exploration ofgenetic markers of these autoimmune diseases is seen as a new and integral part of making progress inunderstanding; it will prov ide vital clues to focus immunological studies in the future leading to directintervention in RA, SS and MS and pointing the way forward for other similar diseases. The nature of thetraining activities in the form of prospective and genetic studies over ma ny years including also clinical studies isa guarantee for the long-term activity.
Original text from CORDIS.
Participants
- UNIVERSITETET I BERGEN · BERGENCoordinatorNorway
- Friedrich-Alexander-Universität Erlangen Nürnberg · ERLANGENCity levelGermany
- KAROLINSKA INSTITUTET · STOCKHOLMSweden
- KLINIKUM DER JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN · FRANKFURT AM MAINCity levelGermany
- LUND UNIVERSITET · LUNDCity levelSweden
- MEDICAL RESEARCH COUNCIL · LONDONUnited Kingdom
Links
Data: CORDIS, © European Union